Additional information
| Strength | 10mg, 2mg, 5mg |
|---|
– CJC-1295 (No DAC)
Price range: $45.00 through $100.00
Product Classification
Classified as a short-acting GHRH analogue
Description
CJC-1295 without DAC is a growth hormone releasing hormone analogue lacking the DAC modification, resulting in shorter duration of action and more physiologic pulsatile signaling characteristics.
Specifications
- Molecular Type: GHRH analogue
- Mechanism: GH/IGF-1 axis stimulation (short-acting)
Research Notes
- Pulsatile GH: supports higher-frequency GH pulse investigations.
- Co-Administration: commonly explored with GHRPs for synergy
- IGF-1: modest increases relative to DAC-modified variant.
- Pharmacokinetics: reduced half-life promotes physiologic signaling windows
Regulatory Statement
For research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease
Related products
-
Cagrisema (Cagrilintide + Semaglutide)
Price range: $80.00 through $135.00 Select options This product has multiple variants. The options may be chosen on the product page -
– Adamax (Peptide Analog Under Investigation)
Price range: $80.00 through $112.00 Select options This product has multiple variants. The options may be chosen on the product page -
– AOD-9604 (Fragment 176-191 Analog)
Price range: $45.00 through $155.00 Select options This product has multiple variants. The options may be chosen on the product page -
– ARA290 (Cibinetide)
Price range: $75.00 through $100.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.